Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220014814 220018189 1.79 71.8 Palliative (P) 2016-05-09 2016-05-09 DAUNORUBICIN 2 N 220035685 CAPECITABINE
220014815 220018189 1.53 29 Palliative (P) 2017-08-04 2017-08-04 Capecitabine N null 220035685 CAPECITABINE + CARBOPLATIN
220014816 220009434 1.75 87.4 Curative (C) 2017-02-08 2017-02-11 Capecitabine 02 N 220035734 BEVACIZUMAB
220014817 220009435 1.63 113 null 2015-01-05 2015-06-21 CAPECITABINE + TEMOZOLOMIDE 02 null 220035735 EOX
220014818 220009436 1.63 112 Palliative (P) 2017-12-11 2017-12-15 ROMAZA TRIAL 2 Y 220035738 CARBOPLATIN
220014819 220009438 0 88 Curative (C) 2017-04-27 2017-06-10 Ipilimumab N 2 220035738 CISPLATIN + DOCETAXEL + FLUOROURACIL
220014822 220015007 1.79 null Palliative (P) 2014-09-09 2015-04-17 IPILIMUMAB + NIVOLUMAB N N 220035760 BORTEZOMIB
220014823 220009444 null null Curative (C) 2012-06-28 2013-08-31 GEM-P N N 220035762 PAD
220014824 220009445 null 60.4 null 2017-11-16 2017-11-23 DOXORUBICIN 2 null 220035765 BEVACIZUMAB + CAPE + OXALIPLATIN
220014825 220009446 1.7 null Curative (C) 2017-01-26 2017-01-28 CHLVPP Y null 220035768 MITOXANTRONE + TRETINOIN
220014826 220009447 1.58 44.8 Palliative (P) 2014-11-30 2015-04-03 ROMAZA TRIAL 02 N 220035777 CAPECITABINE + IRINOTECAN
220014829 220009449 null null Palliative (P) 2013-08-20 2013-11-30 BEP 5 Day null N 220035783 FIGARO TRIAL
220014831 220021021 1.78 101.8 Palliative (P) 2015-09-05 2015-12-09 Cisplatin + Pemetrexed 2 N 220035790 LI-1 TRIAL
220014832 220009450 1.66 70.6 null 2016-09-08 2016-10-07 ALL UKALL2011 Maintenance B3 N N 220035793 PEMBROLIZUMAB
220014833 220015013 1.69 77.2 Curative (C) 2013-03-06 2014-05-04 CLOFARABINE null N 220035797 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220014834 220018194 1.74 null Palliative (P) 2018-07-28 2018-07-28 FLUDARABINE N Y 220035808 BUSULFAN + CYCLOPHOSPHAMIDE
220014835 220018194 null null null 2018-09-09 2018-09-14 Etoposide oral N null 220035808 CAPECITABINE + OXALIPLATIN
220014836 220021599 1.75 69 null 2013-12-08 2013-12-29 TRASTUZUMAB N N 220035815 CLADRIBINE
220014837 220009453 1.65 65.7 Curative (C) 2016-01-08 2016-01-09 CHOP - 21 days N N 220035840 SPIRIT TRIAL
220014838 220009455 1.75 82.9 Palliative (P) 2013-06-12 2013-10-17 CYTARABINE + MITOXANTRONE N N 220035846 SPIRIT TRIAL
220014840 220015016 1.64 null Curative (C) 2014-03-18 2014-03-18 BENDAMUSTINE + RITUXIMAB null N 220035858 CYCLOPHOSPHAMIDE + ETOPOSIDE HD
220014841 220009458 1.67 87.5 Palliative (P) 2015-07-19 2015-12-17 CAPECITABINE + GEMCITABINE N N 220035866 VENETOCLAX
220014842 220009459 null null Curative (C) 2015-03-04 2015-03-09 ALEMTUZUMAB + CYCLO + FLUDARABINE N N 220035867 MITOXANTRONE + TRETINOIN
220014843 220015017 1.8 null Curative (C) 2019-05-09 2019-05-15 CYTARABINE + MITOXANTRONE 01 null 220035870 UKALLR3
220014844 220009460 null null Curative (C) 2015-08-05 2015-08-05 EOX N null 220035874 EOX
220014845 220009462 null null Neo-adjuvant (N) 2014-08-09 2014-08-09 FLUDARABINE N null 220035877 DOXORUBICIN
220014846 220009463 1.8 49.7 Palliative (P) 2016-07-23 2016-07-23 CHLORAMBUCIL + OBINUTUZUMAB 02 N 220035878 UKALL2011
220014847 220009463 1.78 null Curative (C) 2015-04-20 2015-04-21 ALL UKALL2011 Std Int Maint A 02 N 220035878 BENDAMUSTINE + RITUXIMAB
220014848 220009465 null 79.6 Disease modification (D) null 2016-03-17 IVAC 2 N 220035883 IPILIMUMAB + NIVOLUMAB
220014849 220009466 0 64.6 Curative (C) 2014-02-21 2014-02-27 PEMBROLIZUMAB N N 220035885 CETUXIMAB + CISPLATIN + FLUOROURACIL
220014850 220009467 1.49 64 Palliative (P) 2012-06-18 2014-03-19 Cisplatin + Radiotherapy 02 N 220035891 FCR
220014851 220009467 0 73.8 Disease modification (D) 2013-04-15 2013-04-15 Arsenic Triox + Tretinoin Ind W1-4 null N 220035891 ALEMTUZUMAB + CYCLOPHOSPHAMIDE
220014852 220009467 1.78 0 Palliative (P) 2016-12-09 2016-12-10 Cetuximab + CISPLATIN + FLUOROURACIL 02 N 220035891 ALEMTUZUMAB + CYCLO + FLUDARABINE
220014854 220009469 1.7 52.5 Palliative (P) 2014-11-11 2015-01-06 CAPECITABINE + CARBOPLATIN + EPIRUBICIN 02 N 220035911 CISPLATIN
220014855 220009469 null 63.9 Palliative (P) 2016-09-25 2016-10-15 MERCAPTOPURINE + METHOTREXATE + VINCRISTINE N N 220035911 MACE
220014856 220009470 1.71 102.4 Palliative (P) 2014-05-01 2014-05-01 Arsenic Trioxide (Induction Week) null N 220035925 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE
220014857 220018196 1.55 null Curative (C) 2015-03-17 2015-03-21 FLUDARABINE N 2 220035925 FLUDARABINE
220014858 220009472 null 65.3 Palliative (P) 2013-08-14 2013-08-14 FLUDARABINE 02 null 220035943 ARSENIC TRIOXIDE
220014859 220009473 1.64 60.6 Adjuvant (A) null 2016-05-25 Cisplatin + Pemetrexed 02 N 220035947 VENETOCLAX
220014860 220009477 1.6 65 Palliative (P) 2014-11-15 2014-11-15 DABRAFENIB 2 N 220035950 TRASTUZUMAB
220014861 220009478 1.65 81 null 2014-12-03 2014-12-03 Bevacizumab 5mg/kg 02 N 220035951 DABRAFENIB
220014862 220009478 1.68 83.9 Palliative (P) 2013-12-19 2014-03-28 Alemtuzumab+Busulfan+CyclophosphMUD null null 220035951 MELPHALAN
220014863 220018199 1.58 61 Palliative (P) null 2017-02-04 DOXORUBICIN Y null 220035957 CARBOPLATIN + LIPOSOMAL DOX
220014864 220009479 1.69 72.5 Adjuvant (A) 2017-05-14 2017-05-26 RAVVA TRIAL N N 220035959 BUSULPHAN
220014865 220009481 null null Palliative (P) 2017-04-12 2017-04-12 FLUDARABINE 02 N 220035962 DAUNORUBICIN
220014866 220009482 null 67 null 2017-04-03 2017-04-03 Bortezomib +/- Dexamethasone N null 220035963 METHOTREXATE HIGH DOSE
220014867 220009483 1.75 100 Curative (C) null 2016-06-01 ALL UKALL2011 Maintenance A3 N N 220035969 CAPECITABINE
220014868 220009484 1.74 108 Not known (9) 2014-11-04 2014-11-04 Cisplatin + Docetaxel +Fluorouracil 01 N 220035980 SUNITINIB
220014869 220015032 1.73 94.2 Curative (C) null 2015-10-04 Bevacizumab 5mg/kg N null 220035982 FIGARO TRIAL
220014870 220015032 1.76 76.6 Curative (C) 2016-07-16 2016-08-05 NIVOLUMAB 02 N 220035982 FLUOROURACIL + IRINOTECAN + OXALIPLATIN